Rejection After Auxiliary Partial Orthotopic Liver Transplantation: An Exploratory Comparison by Native-Liver Cirrhosis Status
A legfontosabb adatok
- Ki végzi
- Zhi-Jun Zhu
- Hol
- Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 44 fő vett részt
- Kezdés
- 2025. dec. 1.
- Befejezés
- 2026. jún. 30.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A regiszteradat frissítve
- 2026. november 2.
Ki vehet részt
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 8 feltétel megnézéseKevesebb
Ki vehet részt
- Recipients who underwent auxiliary partial orthotopic liver transplantation (APOLT) at Beijing Friendship Hospital, Capital Medical University, between 2014 and 2025
- Patients with a confirmed underlying liver disease
- Patients without a history of previous solid-organ transplantation
- Patients with available histopathological examination of native-liver tissue obtained during the initial APOLT procedure, allowing classification of native-liver cirrhosis status
- Patients with sufficient clinical records and follow-up information to establish baseline characteristics, operative variables, and the occurrence and timing of the primary outcome or the applicable censoring time
Ki nem vehet részt
- Patients who underwent APOLT for acute or subacute liver failure
- Patients with idiopathic portal hypertension without histopathological evidence of cirrhosis
- Patients with insufficient clinical or follow-up data to determine eligibility, classify native-liver cirrhosis status, or assess the primary outcome
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
This retrospective single-center cohort study aims to investigate the association between native-liver cirrhosis status and post-transplant outcomes in recipients undergoing auxiliary partial orthotopic liver transplantation (APOLT). A total of 44 recipients who underwent APOLT between 2014 and 2025 will be included and classified into non-cirrhotic and cirrhotic groups according to the histopathological findings of the retained native liver. The study will compare biopsy-proven rejection, including first and recurrent rejection episodes, postoperative complications, overall survival, and graft survival between the two groups. The findings may help improve understanding of the relationship between native-liver cirrhosis status and post-transplant outcomes and provide evidence for future clinical research and individualized post-transplant management.
A vizsgálat 2 csoportja
- Non-cirrhotic native liver
Recipients undergoing APOLT whose retained native liver showed no histopathological evidence of cirrhosis. A total of 11 recipients were included in this cohort. Outcomes were assessed retrospectively based on medical records, including biopsy-proven rejection, postoperative complications, overall survival, and graft survival.
- Cirrhotic native liver
Recipients undergoing APOLT whose retained native liver showed histopathological evidence of cirrhosis. A total of 33 recipients were included in this cohort. Outcomes were assessed retrospectively based on medical records, including biopsy-proven rejection, postoperative complications, overall survival, and graft survival.
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2026. november 2.